Boston Scientific (BSX) Equity Ratio (2009 - 2026)

Boston Scientific has disclosed Equity Ratio across 18 years of filings, most recently posting 0.59 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.59, up 5.25% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.59 (up 5.25% YoY), and the FY2025 annual result was 0.55, changed 0.41% from the prior year.
• Equity Ratio came in at 0.59 for Q1 2026 at Boston Scientific, up from 0.55 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.62 in Q1 2022 to a low of 0.07 in Q2 2023.
• The 5-year median for Equity Ratio is 0.55 (2024), against an average of 0.37.
• Across the five-year window, Equity Ratio surged 112560.73% in 2022 and plunged 414.48% in 2025, its largest moves.
• Boston Scientific's Equity Ratio stood at 0.02 in 2022, then jumped by 2506.34% to 0.56 in 2023, then slipped by 0.58% to 0.55 in 2024, then gained by 0.41% to 0.55 in 2025, then increased by 6.07% to 0.59 in 2026.
• The last three Equity Ratio figures came in at 0.59 (Q1 2026), 0.55 (Q4 2025), and 0.55 (Q3 2025), per Business Quant data.